Interestingly, sub-apoptotic doses of SKI-II also reduced the activation and proliferation of CLL cells induced by different signals that mimic the tumor microenvironment, including anti-IgM plus CD40L (19). Here, CD40LG is linked to B-cell chronic lymphocytic leukemia.